Hemant Parekh

897 total citations
37 papers, 773 citations indexed

About

Hemant Parekh is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Hemant Parekh has authored 37 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Hemant Parekh's work include Cancer therapeutics and mechanisms (6 papers), Microtubule and mitosis dynamics (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Hemant Parekh is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Microtubule and mitosis dynamics (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Hemant Parekh collaborates with scholars based in United States, India and Slovakia. Hemant Parekh's co-authors include Henry Simpkins, M.P. Chitnis, T.S. Srivastava, Jianli Chen, Kuan‐Chih Chow, H. Mansuri‐Torshizi, Renu Mital, Charalambos Solomides, Fiona Simpkins and Steven R. Houser and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gene.

In The Last Decade

Hemant Parekh

36 papers receiving 755 citations

Peers

Hemant Parekh
Tami Annable United States
András Jeney Hungary
Jean Veith United States
Donna Carr United States
Guangan He United States
Eva‐Laure Matera France
Giacomo Cossa Italy
Dario Ballinari Italy
Vishal Pendharkar Singapore
Gabriela Tudor United States
Tami Annable United States
Hemant Parekh
Citations per year, relative to Hemant Parekh Hemant Parekh (= 1×) peers Tami Annable

Countries citing papers authored by Hemant Parekh

Since Specialization
Citations

This map shows the geographic impact of Hemant Parekh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant Parekh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant Parekh more than expected).

Fields of papers citing papers by Hemant Parekh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemant Parekh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant Parekh. The network helps show where Hemant Parekh may publish in the future.

Co-authorship network of co-authors of Hemant Parekh

This figure shows the co-authorship network connecting the top 25 collaborators of Hemant Parekh. A scholar is included among the top collaborators of Hemant Parekh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemant Parekh. Hemant Parekh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gajarski, Robert J., et al.. (2024). DQB1 antigen matching improves rejection-free survival in pediatric heart transplant recipients. The Journal of Heart and Lung Transplantation. 43(5). 816–825. 1 indexed citations
2.
Hayes, Don, Rachael E. Rayner, Cynthia L. Hill, et al.. (2020). Airway epithelial stem cell chimerism in cystic fibrosis lung transplant recipients. Journal of Cystic Fibrosis. 20(1). 165–172. 10 indexed citations
3.
Chen, Jianli, Charalambos Solomides, Hemant Parekh, Fiona Simpkins, & Henry Simpkins. (2015). Cisplatin resistance in human cervical, ovarian and lung cancer cells. Cancer Chemotherapy and Pharmacology. 75(6). 1217–1227. 44 indexed citations
4.
Chen, Jianli, et al.. (2007). Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 61(6). 979–987. 54 indexed citations
5.
6.
Isordia‐Salas, Irma, Joanne M. Manns, Irma M. Sáinz, Hemant Parekh, & Raul A. DeLa Cadena. (2005). Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line. Thrombosis Research. 116(6). 533–543. 7 indexed citations
7.
Parekh, Hemant, et al.. (2002). Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma Cells. Journal of Biological Chemistry. 277(17). 15035–15043. 80 indexed citations
8.
Sharma, Indu, et al.. (1998). Lipid changes during in vitro capacitation of the buffalo spermatozoa. The Indian Journal of Animal Sciences. 68(10). 1030–1031. 1 indexed citations
9.
Parekh, Hemant, et al.. (1997). Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochemical Pharmacology. 53(4). 461–470. 80 indexed citations
10.
Parekh, Hemant & Henry Simpkins. (1997). The transport and binding of taxol. General Pharmacology The Vascular System. 29(2). 167–172. 45 indexed citations
11.
Parekh, Hemant & Henry Simpkins. (1996). Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Biochemical Pharmacology. 51(3). 301–311. 21 indexed citations
12.
Parekh, Hemant & Henry Simpkins. (1996). Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 37(5). 457–462. 25 indexed citations
13.
Parekh, Hemant & Norman E. Sládek. (1993). NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochemical Pharmacology. 46(6). 1043–1052. 15 indexed citations
14.
Parekh, Hemant, H. Mansuri‐Torshizi, T.S. Srivastava, & M.P. Chitnis. (1992). Circumvention of Adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells. Cancer Letters. 61(2). 147–156. 19 indexed citations
15.
Mansuri‐Torshizi, H., T.S. Srivastava, Hemant Parekh, & M.P. Chitnis. (1992). Synthesis, spectroscopic, cytotoxic, and DNA binding studies of binuclear 2,2′-bipyridine-platinum(II) and -palladium (II) complexes of meso-α,α′-diaminoadipic and meso-α,α′-diaminosuberic acids. Journal of Inorganic Biochemistry. 45(2). 135–148. 61 indexed citations
16.
Mital, Renu, T.S. Srivastava, Hemant Parekh, & M.P. Chitnis. (1991). Synthesis, characterization, DNA binding, and cytotoxic studies of some mixed-ligand palladium(II) and platinum(II) complexes of α-diimine and amino acids. Journal of Inorganic Biochemistry. 41(2). 93–103. 62 indexed citations
17.
Parekh, Hemant, et al.. (1991). Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells. Anti-Cancer Drugs. 2(2). 159–168. 4 indexed citations
18.
Parekh, Hemant, Sonali D. Advani, & M.P. Chitnis. (1990). Bepridil Enhances Adriamycin-Induced DNA Biosynthesis Inhibition in Human Myeloid Leukemia Cells. PubMed. 6(4). 183–191. 1 indexed citations
19.
20.
Parekh, Hemant & M.P. Chitnis. (1990). Effect of Alterations in Permeability by Nonionic Surfactants on Adriamycin Cytotoxicity in Murine Tumor Models in vitro. Oncology. 47(6). 501–507. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tami Annable Breakdown of academic impact, for papers by András Jeney Breakdown of academic impact, for papers by Jean Veith Breakdown of academic impact, for papers by Donna Carr Breakdown of academic impact, for papers by Guangan He Breakdown of academic impact, for papers by Eva‐Laure Matera Breakdown of academic impact, for papers by Giacomo Cossa Breakdown of academic impact, for papers by Dario Ballinari Breakdown of academic impact, for papers by Vishal Pendharkar Breakdown of academic impact, for papers by Gabriela Tudor
Rankless by CCL
2026